Catalyst Pharmaceutical Partners Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (28)

Latest Posts

About This Stock More About This Stock
5 Stocks Analysts Recommend Heading Into 2020
Article By: Benzinga
Wednesday, January 1, 2020 2:37 PM EDT
The S&P 500 closed out 2019 with another strong month in December. However, analysts remain optimistic on some top stocks heading into 2020. Here’s a look at several stocks analysts recommend.
In this article: GLUU, AMZN, CPRX, VSLR, VKTX
Read
Catalyst Defends Firdapse Pricing In Response Letter To Bernie Sanders
Article By: The Fly
Thursday, February 21, 2019 4:08 PM EDT
The pharmaceutical company takes exception to Sanders' complaint.
In this article: CPRX
Read
2 Hot Biotechs With Major FDA Catalysts
Article By: TipRanks
Wednesday, October 24, 2018 4:58 AM EDT
Biotech stocks can soar or plunge depending on FDA decisions. There’s no doubt that buying ahead of PDUFA dates is a risky call.
In this article: ACRX, CPRX Also: TXMD, OCUL
Read
Why You Should Pass On Investing In This $3.00 Drug Stock
Article By: Bret Jensen
Tuesday, November 3, 2015 12:19 PM EDT
I dived in deeper myself before making any decision to recommend this company as a holding. Catalyst Pharmaceuticals (CPRX) goes for just over $3.00 a share and has been getting some positive attention from analysts recently.
In this article: VRX, CPRX
Read
Sell Signals - NPTN OSN UUU HF CPRX
Article By: Jim Van Meerten
Thursday, August 13, 2015 8:15 PM EDT
This week I deleted the following stocks for negative price momentum: Neophotonics, Ossen Innovation, Universal Security Instruments, HFF and Catalyst Pharmaceuticals.
In this article: HF, NPTN, UUU, OSN, CPRX
Read

PARTNER HEADLINES

Latest Tweets for $CPRX

No tweets yet!